Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Special Feature
  • Published:

NICHD Conference on Kernicterus: Research on Prevention of Bilirubin-Induced Brain Injury and Kernicterus: Bench-to-Bedside—Diagnostic Methods and Prevention and Treatment Strategies

Abstract

In July 2003, the National Institute of Child Health and Human Development (NICHD) organized a consensus conference, where a group of experts were invited to review and discuss the current state of knowledge regarding neonatal hyperbilirubinemia and identify areas in which where future research should be directed. This paper summarizes the presentations addressing the current methodologies for direct and noninvasive assessments of serum total bilirubin concentrations as well as prevention and treatment strategies for the management of neonatal hyperbilirubinemia.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Vreman HJ, Verter J, Oh W, et al. Interlaboratory variability of bilirubin measurements. Clin Chem 1996;42:869–873.

    CAS  PubMed  Google Scholar 

  2. Tenhunen R, Marver HS, Schmid R . The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 1968;61:748–755.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Weiss JS, Gautman A, Lauff JJ, et al. The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. N Engl J Med 1983;309:147–150.

    Article  CAS  PubMed  Google Scholar 

  4. McDonagh AF, Palma LA, Lauff JJ, Wu TW . Origin of mammalian biliprotein and rearrangement of bilirubin glucuronides in vivo in the rat. J Clin Invest 1984;74:763–770.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. McDonagh AF, Lightner DA . Like a shrivelled blood orange'—bilirubin, jaundice, and phototherapy. Pediatrics 1985;75:443–455.

    CAS  PubMed  Google Scholar 

  6. Ahlfors CE . Measurement of plasma unbound unconjugated bilirubin. Anal Biochem 2000;279:130–135.

    Article  CAS  PubMed  Google Scholar 

  7. Yamanouchi I, Yamauchi Y, Igarashi I . Transcutaneous bilirubinometry: preliminary studies of noninvasive transcutaneous bilirubin meter in the Okayama National Hospital. Pediatrics 1980;65:195–202.

    CAS  PubMed  Google Scholar 

  8. Yasuda S, Itoh S, Isobe K, et al. New transcutaneous jaundice device with two optical paths. J Perinat Med 2003;31:81–88.

    PubMed  Google Scholar 

  9. Bhutani VK, Gourley GR, Adler S, Kreamer B, Dalin C, Johnson LH . Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics 2000;106:E17–E25.

    Article  CAS  PubMed  Google Scholar 

  10. Bhutani VK, Johnson L, Sivieri EM . Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999;103:6–14.

    Article  CAS  PubMed  Google Scholar 

  11. Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics 2001;108:31–39.

    Article  CAS  PubMed  Google Scholar 

  12. McDonagh AF, Lightner DA . Phototherapy and the photobiology of bilirubin. Semin Liver Dis 1988;8:272–283.

    Article  CAS  PubMed  Google Scholar 

  13. Tan KL . Efficacy of fluorescent daylight, blue, and green lamps in the management of nonhemolytic hyperbilirubinemia. J Pediatr 1989;114:132–137.

    Article  CAS  PubMed  Google Scholar 

  14. Vreman HJ, Wong RJ, Murdock JR, Stevenson DK . In vitro efficacy of an LED-based phototherapy device (neoBlue™) compared to traditional light sources. Pediatr Res 2003;53:400A.

    Google Scholar 

  15. Aouthmany MM . Phototherapy increases hemoglobin degradation and bilirubin production in preterm infants. J Perinatol 1999;19:271–274.

    Article  CAS  PubMed  Google Scholar 

  16. Wong RJ, Vreman HJ, Stevenson DK . (Metallo)porphyrin inhibitors of heme oxygenase also inhibit lipid peroxidation (LP). Pediatr Res 2000;47:465.

    Google Scholar 

  17. Appleton SD, Chretien ML, McLaughlin BE, et al. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. Drug Metab Dispos 1999;27:1214–1219.

    CAS  PubMed  Google Scholar 

  18. Vreman HJ, Ekstrand BC, Stevenson DK . Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Pediatr Res 1993;33:195–200.

    Article  CAS  PubMed  Google Scholar 

  19. Zhang W, Contag PR, Hardy J, et al. Selection of potential therapeutics based on in vivo spatiotemporal transcription patterns of heme oxygenase-1. J Mol Med 2002;80:655–664.

    Article  CAS  PubMed  Google Scholar 

  20. Wong RJ, Abate A, Dennery PA, Vreman HJ, Contag CH, Stevenson DK . Intestinal absorption of metalloporphyrins and systemic effects on heme oxygenase. Pediatr Res 2003;53:400A.

    Google Scholar 

  21. Vreman HJ, Wong RJ, Stevenson DK . Alternative metalloporphyrins for the treatment of neonatal jaundice. J Perinatol 2001;21 (Suppl 1):S108–S113.

    Article  PubMed  Google Scholar 

  22. Valaes T, Petmezaki S, Henschke C, Drummond GS, Kappas A . Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Pediatrics 1994;93:1.

    CAS  PubMed  Google Scholar 

  23. Martinez JC, Garcia HO, Otheguy LE, Drummond GS, Kappas A . Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics 1999;103:1–5.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Institutes of Health, grants HL68703 (D.K.S.), HL58013 (D.K.S.), DK26307 (A.F.M.), and HD17779 (D.A.L.), and unrestricted gifts from the Mary L. Johnson, H. M. Lui, and Hess Research Funds (DKS).

Author information

Authors and Affiliations

Authors

Additional information

Presented in part at the NICHD Conference, Research on Prevention of Bilirubin-Induced Brain Injury and Kernicterus-From Bench to Bedside at Bethesda, MD; USA; June 2003.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stevenson, D., Wong, R., Vreman, H. et al. NICHD Conference on Kernicterus: Research on Prevention of Bilirubin-Induced Brain Injury and Kernicterus: Bench-to-Bedside—Diagnostic Methods and Prevention and Treatment Strategies. J Perinatol 24, 521–525 (2004). https://doi.org/10.1038/sj.jp.7211124

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211124

This article is cited by

Search

Quick links